After a decade of extraordinary growth, Australia’s ETF industry entered 2025 in a more mature phase of its evolution. No ...

Antipodes Healthcare Portfolio Manager, Nick Cameron highlighted why Antipodes believes Merck & Co is entering 2026 at an ...

The forces driving Australia’s crypto market today aren’t the ones most people assume. Older Australians and women are now ...

For those playing along at home, the stock is 4DMedical Ltd ( ASX: 4DX), which has skyrocketed more than 1,000% in the second ...

MYEFO delivered a modest deficit upgrade, but long-term spending pressures continue to cloud Australia’s fiscal outlook.

Despite being tipped as an income name, MQG finished 2025 with a -5.58% total return, as a 9.06% share price decline ...

With hybrids phasing out, investors are finding attractive yields in a range of new listed investments coming to market.

The bull market is not over, but it is changing. Two major brokers explain why selectivity and earnings matter more than ever.

Future Generation Australia proves there’s no need to forgo performance for charity with the right structure and portfolio.

Kip McGrath (ASX:KME) has a decades long track record of growth and an experienced capital allocator chairing the board.

The share market return is more volatile than keeping all, or some, of your money earning interest from a cash investment. So ...

The U.S. added a modest 64,000 jobs in November, slightly above expectations, reinforcing the notion that the labor market is ...